<< Read Full Article
<< Read Full Article
Celgene Shares Hit Hard on Warning
Shares of Celgene (CELG Quote) were down nearly 15% after the biotech company said that first-quarter and full-year profit and sales would miss Wall Street expectations.
The company is expecting revenue to be about $600 million in the quarter, below expectations for $647.1 million. The full-year EPS is expected to come in at the low end of the $2.05 to $2.15 per share range, missing the consensus for $2.17....
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,388.90 | 1,105.98 | 2,194.35 | 34.83 |
Oil *
77.74
|
|
UP
22.75
|
UP
6.06
|
UP
21.21
|
UP
1.03
|
10 Yr
3.48%
SPDR Gold
113.75
|
|
+0.22%
|
+0.55%
|
+0.98%
|
+3.05%
|
Data delayed 20 minutes |
Connect with TheStreet